バイオ原料の世界市場レポート 2025年

バイオ原料市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.9％で835億米ドルに成長します。予測期間の成長は、個別化栄養への注目、細胞ベースの食肉生産の拡大、治療用バイオ原料の開発、廃棄物削減のためのバイオ原料、バイオプラスチックへのシフトに起因します。予測期間の主な動向には、バイオテクノロジーに基づく機能性食品、循環型経済実践のためのバイオテクノロジー・ソリューション、治療用バイオテクノロジー原料、クリーン・エネルギー生産のためのバイオテクノロジー原料、生物多様性保全の世界的重視などがあります。

ジェネリック医薬品の需要の増加は、今後のバイオ原料市場の成長を牽引すると予想されます。ジェネリック医薬品とは、以前に承認された医薬品と同じ特性を持つように設計された医薬品のことです。ジェネリック医薬品においてバイオ医薬品原料は重要な役割を担っており、先発品に酷似した様々な有効成分を生産するための費用対効果に優れた効率的な供給源として、厳しい規制基準の対象となっています。例えば、米国を拠点とする専門家会員組織である個別化医療連合によると、2022年に承認された12の個別化新薬は、新たに承認された治療法全体の約34%に相当し、以前に比べて顕著に増加しています。このように、ジェネリック医薬品に対する需要の高まりが、バイオ原料市場の成長を後押ししています。

バイオ原料市場の成長に大きく貢献しているのは、パーソナルケア製品に対する需要の増加です。パーソナルケア製品は、個人の衛生や外見向上のためのアイテムを含み、環境フットプリントの削減、持続可能性、一貫した品質、アレルギーの可能性の低減、生体適合性、効能の向上、石油化学製品への依存度の低減などの利点を提供するバイオテクノロジー成分を利用しています。労働統計局の報告によると、2022年、パーソナルケア製品に対する消費者の平均支出は12.3％増加し、866ドルに達しました。この消費者支出の伸びは、パーソナルケア製品に対する需要の増加を反映しており、この市場におけるバイオテクノロジー原料の需要を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界バイオ原料PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界のバイオ原料市場：成長率分析
• 世界のバイオ原料市場の実績：規模と成長, 2019-2024
• 世界のバイオ原料市場の予測：規模と成長, 2024-2029, 2034F
• 世界バイオ原料総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバイオ原料市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品有効成分
• バイオシミラー
• 世界のバイオ原料市場表現システムによる、実績と予測, 2019-2024, 2024-2029F, 2034F
• 哺乳類発現システム
• 微生物発現システム
• 酵母発現システム
• 植物発現システム
• 昆虫発現システム
• 世界のバイオ原料市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 飲食品
• パーソナルケアと化粧品
• クリーニング製品
• その他の用途
• 世界のバイオ原料市場、医薬品有効成分（API）の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生物学的API
• 合成API
• 世界のバイオ原料市場、バイオシミラーのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• モノクローナル抗体
• 組み換えタンパク質
• インスリンバイオシミラー

第7章 地域別・国別分析

• 世界のバイオ原料市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバイオ原料市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオ原料市場：競合情勢
• バイオ原料市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • International Flavors & Fragrance（IFF）Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan Inc.
• Boehringer Ingelheim International GmbH.
• AstraZeneca plc.
• Givaudan
• Firmenich SA
• Amyris Inc.
• Advanced BioTech
• Sollice Biotech
• Novocap S.A.
• Eli Lilly
• Bristol-Myers Squibb Company
• GlaxoSmithKline plc.
• F. Hoffmann-La Roche AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バイオ原料市場2029：新たな機会を提供する国
• バイオ原料市場2029：新たな機会を提供するセグメント
• バイオ原料市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Biotech ingredients encompass chemical components produced by microbes, notably yeast, yeast-such as organisms, or algae, whose DNA has been modified to generate commercially viable compounds through their metabolic processes. These ingredients offer enhanced safety and often present a more cost-effective option for consumers.

The primary categories of biotech ingredients include active pharmaceutical ingredients (APIs) and biosimilars. APIs constitute components within over-the-counter or prescription medications that induce the intended health effects. These ingredients utilize diverse expression systems such as mammalian, microbial, yeast, plant, and insect systems, applied across various sectors such as food and beverages, personal care and cosmetics, cleaning products, and other industries.

The biotech ingredient market research report is one of a series of new reports from The Business Research Company that provides biotech ingredient market statistics, including biotech ingredient industry global market size, regional shares, competitors with a biotech ingredient market share, detailed biotech ingredient market segments, market trends and opportunities, and any further data you may need to thrive in the biotech ingredient industry. This biotech ingredient market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biotech ingredient market size has grown strongly in recent years. It will grow from $59.9 billion in 2024 to $63.86 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to innovations in food and beverage industry, increasing adoption of biofuel, consumer demand for functional foods, advances in genetic engineering.

The biotech ingredient market size is expected to see strong growth in the next few years. It will grow to $83.5 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to focus on personalized nutrition, expansion of cell-based meat production, development of therapeutic biotech ingredients, bio ingredients for waste reduction, shift towards bioplastics. Major trends in the forecast period include biotech-based functional foods, biotech solutions for circular economy practices, therapeutic biotech ingredients, biotech ingredients for clean energy production, global emphasis on biodiversity conservation.

The increasing demand for generic medicines is expected to drive the growth of the biotech ingredient market in the future. A generic medicine is a drug designed to possess the same properties as a previously approved medication. Biotech ingredients play a crucial role in generic medicine, serving as a cost-effective and efficient source for producing a variety of active ingredients that closely resemble the original products and are subject to stringent regulatory standards. For example, according to the Personalized Medicine Coalition, a US-based professional membership organization, the approval of 12 new personalized medicines in 2022 represented approximately 34% of all newly approved therapies, reflecting a notable increase compared to prior years. Thus, the rising demand for generic medicines is fueling the growth of the biotech ingredient market.

A significant factor contributing to the growth of the biotech ingredient market is the increasing demand for personal care products. Personal care products, encompassing items for personal hygiene and appearance enhancement, utilize biotech ingredients that offer benefits such as a reduced environmental footprint, sustainability, consistent quality, reduced allergenic potential, biocompatibility, enhanced efficacy, and reduced dependence on petrochemicals. In 2022, the average consumer expenditure on personal care products increased by 12.3%, reaching $866, as reported by the Bureau of Labor Statistics. This growth in consumer spending reflects the increasing demand for personal care products, driving the demand for biotech ingredients in this market.

A key trend in the biotech ingredient market is technological advancement, with major companies introducing new technologies to develop innovative products and strengthen their market position. For example, in March 2023, International Flavors & Fragrances Inc., a U.S.-based manufacturer, launched Aurist AGC, a novel biopolymer for hair care. Leveraging the Designed Enzymatic Biopolymers (DEB) technology, this biotechnology platform produces unique biobased polysaccharides with distinct structures and product features. The introduction of such innovative technologies highlights the commitment of major companies to staying at the forefront of the biotech ingredient market.

Prominent companies in the biotech ingredient market are strategically focusing on innovative products to drive revenue growth. One such example is the emphasis on biosyn-bisabolol, a sesquiterpene component found in nature known for its skin protection properties, anti-inflammatory effects, skin-soothing attributes, and barrier restoration capabilities. Aneco Chemicals Co. Ltd., a China-based specialty ingredient maker, showcased its commitment to innovation by launching biosyn-bisabolol in June 2023. This sustainable product is derived through a green production approach that preserves biodiversity and benefits the ecosystem. With a minimum assay of 95%, biosyn-bisabolol is entirely composed of bio-based carbon, making it suitable for use in skin care and sun care products. It can be seamlessly combined with various cosmetic ingredients. The creation of biosyn-bisabolol involved a unique technology ensuring excellent purity, quality, and heightened physiological activity.

In February 2022, Kerry Group plc, an Ireland-based taste and nutrition company, made a significant acquisition by acquiring c-LEcta for $226 million. This acquisition aligns with Kerry's goal to strengthen its innovation activities in enzymatic engineering, fermentation, and biotechnological development. Additionally, Kerry plans to invest in cutting-edge sustainable technologies to drive the development of sustainable food and health systems in the future. c-LEcta, based in Germany, is a biotechnology innovation firm specializing in highly precise fermentation, optimized bio-processing, and bio-transformation to produce high-value targeted biomolecules and ingredients. This strategic acquisition demonstrates the commitment of major companies to advancing their capabilities in the dynamic and innovative field of biotech ingredients.

Major companies operating in the biotech ingredient market include Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Europe was the largest region in the biotech ingredient market in 2024. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biotech ingredient market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biotech ingredient market consists of sales of shea butter, coconut oil, mango butter, frankincense essential oil, patchouli essential oil, and licorice extract. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biotech Ingredient Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biotech ingredient market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biotech ingredient ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biotech ingredient market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Active Pharmaceutical Ingredients; Biosimilars
• 2) By Expression Systems: Mammalian Expression Systems; Microbial Expression Systems; Yeast Expression Systems; Plant Expression Systems; Insect Expression Systems
• 3) By Application: Food And Beverages; Personal Care And Cosmetics; Cleaning Products; Other Applications
• Subsegments:
• 1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs; Synthetic APIs
• 2) By Biosimilars: Monoclonal Antibodies; Recombinant Proteins; Insulin Biosimilars
• Companies Mentioned: Merck & Co. Inc.; Sanofi S.A.; AbbVie Inc.; International Flavors & Fragrance (IFF) Inc.; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biotech Ingredient Market Characteristics

3. Biotech Ingredient Market Trends And Strategies

4. Biotech Ingredient Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Biotech Ingredient Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biotech Ingredient PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biotech Ingredient Market Growth Rate Analysis
• 5.4. Global Biotech Ingredient Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biotech Ingredient Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biotech Ingredient Total Addressable Market (TAM)

6. Biotech Ingredient Market Segmentation

• 6.1. Global Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Active Pharmaceutical Ingredients
• Biosimilars
• 6.2. Global Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mammalian Expression Systems
• Microbial Expression Systems
• Yeast Expression Systems
• Plant Expression Systems
• Insect Expression Systems
• 6.3. Global Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Food And Beverages
• Personal Care And Cosmetics
• Cleaning Products
• Other Applications
• 6.4. Global Biotech Ingredient Market, Sub-Segmentation Of Active Pharmaceutical Ingredients (APIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologic APIs
• Synthetic APIs
• 6.5. Global Biotech Ingredient Market, Sub-Segmentation Of Biosimilars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Recombinant Proteins
• Insulin Biosimilars

7. Biotech Ingredient Market Regional And Country Analysis

• 7.1. Global Biotech Ingredient Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biotech Ingredient Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biotech Ingredient Market

• 8.1. Asia-Pacific Biotech Ingredient Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biotech Ingredient Market

• 9.1. China Biotech Ingredient Market Overview
• 9.2. China Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biotech Ingredient Market

• 10.1. India Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biotech Ingredient Market

• 11.1. Japan Biotech Ingredient Market Overview
• 11.2. Japan Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biotech Ingredient Market

• 12.1. Australia Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biotech Ingredient Market

• 13.1. Indonesia Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biotech Ingredient Market

• 14.1. South Korea Biotech Ingredient Market Overview
• 14.2. South Korea Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biotech Ingredient Market

• 15.1. Western Europe Biotech Ingredient Market Overview
• 15.2. Western Europe Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biotech Ingredient Market

• 16.1. UK Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biotech Ingredient Market

• 17.1. Germany Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biotech Ingredient Market

• 18.1. France Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biotech Ingredient Market

• 19.1. Italy Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biotech Ingredient Market

• 20.1. Spain Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biotech Ingredient Market

• 21.1. Eastern Europe Biotech Ingredient Market Overview
• 21.2. Eastern Europe Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biotech Ingredient Market

• 22.1. Russia Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biotech Ingredient Market

• 23.1. North America Biotech Ingredient Market Overview
• 23.2. North America Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biotech Ingredient Market

• 24.1. USA Biotech Ingredient Market Overview
• 24.2. USA Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biotech Ingredient Market

• 25.1. Canada Biotech Ingredient Market Overview
• 25.2. Canada Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biotech Ingredient Market

• 26.1. South America Biotech Ingredient Market Overview
• 26.2. South America Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biotech Ingredient Market

• 27.1. Brazil Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biotech Ingredient Market

• 28.1. Middle East Biotech Ingredient Market Overview
• 28.2. Middle East Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biotech Ingredient Market

• 29.1. Africa Biotech Ingredient Market Overview
• 29.2. Africa Biotech Ingredient Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biotech Ingredient Market, Segmentation By Expression Systems, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biotech Ingredient Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biotech Ingredient Market Competitive Landscape And Company Profiles

• 30.1. Biotech Ingredient Market Competitive Landscape
• 30.2. Biotech Ingredient Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. International Flavors & Fragrance (IFF) Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Biotech Ingredient Market Other Major And Innovative Companies

• 31.1. Pfizer Inc.
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Mylan Inc.
• 31.4. Boehringer Ingelheim International GmbH.
• 31.5. AstraZeneca plc.
• 31.6. Givaudan
• 31.7. Firmenich SA
• 31.8. Amyris Inc.
• 31.9. Advanced BioTech
• 31.10. Sollice Biotech
• 31.11. Novocap S.A.
• 31.12. Eli Lilly
• 31.13. Bristol-Myers Squibb Company
• 31.14. GlaxoSmithKline plc.
• 31.15. F. Hoffmann-La Roche AG

32. Global Biotech Ingredient Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biotech Ingredient Market

34. Recent Developments In The Biotech Ingredient Market

35. Biotech Ingredient Market High Potential Countries, Segments and Strategies

• 35.1 Biotech Ingredient Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biotech Ingredient Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biotech Ingredient Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer